MARKET

OPTN

OPTN

Optinose
NASDAQ
1.480
0.000
0.00%
After Hours: 1.460 -0.02 -1.35% 19:46 03/27 EDT
OPEN
1.430
PREV CLOSE
1.480
HIGH
1.490
LOW
1.430
VOLUME
404.61K
TURNOVER
0
52 WEEK HIGH
2.100
52 WEEK LOW
0.9000
MARKET CAP
166.72M
P/E (TTM)
-4.6747
1D
5D
1M
3M
1Y
5Y
Lake Street Remains a Buy on Optinose (OPTN)
TipRanks · 1d ago
Weekly Report: what happened at OPTN last week (0318-0322)?
Weekly Report · 3d ago
Institutional investors may adopt severe steps after OptiNose, Inc.'s (NASDAQ:OPTN) latest 13% drop adds to a year losses
Institutional investors own over 50% of OptiNose, Inc. (NASDAQ:OPTN) The top 7 shareholders of the company own 51% of the stock. The company has a high level of institutional ownership, but this could be due to the nature of the firm's business. The recent share price drop of 13% for Opti nose suggests the company is sensitive to its owners. Optinose is owned by a group of 55% of the company, and has a market capitalization of US$184m. It's important to look at the company's ownership of shares to see who really controls the company.
Simply Wall St · 4d ago
Optinose Is Maintained at Buy by Lake Street
Dow Jones · 03/18 13:44
Optinose Price Target Raised to $4.00/Share From $3.00 by Lake Street
Dow Jones · 03/18 13:44
Lake Street Maintains Buy on OptiNose, Raises Price Target to $4
Benzinga · 03/18 13:34
Health Care Sector Update for 03/18/2024: FENC, OPTN, HLN, PFE, XLV, IBB
NASDAQ · 03/18 13:16
Lake Street Sticks to Their Buy Rating for Optinose (OPTN)
TipRanks · 03/18 12:45
More
About OPTN
OptiNose, Inc. is a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists. The Company's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The Company has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.

Webull offers OptiNose Inc stock information, including NASDAQ: OPTN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPTN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPTN stock methods without spending real money on the virtual paper trading platform.